Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipocalin-15 (LCN15) is a small, secreted protein belonging to the lipocalin family, a class of β-barrel proteins specialized in binding small hydrophobic molecules[1][3][4]. LCN15 is specifically and abundantly expressed in Bowman's glands within the olfactory mucosa and secreted into the olfactory mucus[4]. Unlike other lipocalins with roles in transport, immune modulation, and signaling, the primary recognized function of LCN15 is as a constituent of olfactory mucus, potentially supporting olfactory tissue health and serving as a marker of olfactory gland activity[4]. Its pronounced localization and abundance in the olfactory cleft reflect its potential importance in maintaining the microenvironment of the olfactory epithelium. LCN15 is absent or significantly reduced in respiratory mucus. Diminished LCN15 levels correlate with olfactory mucosal atrophy and idiopathic olfactory loss, indicating biomarker potential for olfactory gland function but not established links to common systemic diseases or pharmacological targeting[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipocalin-15 (LCN15).